NYSEARCA:XPH

SPDR S&P Pharmaceuticals ETF (XPH) Price, Holdings, & News

SPDR S&P Pharmaceuticals ETF logo
$61.04 0.00 (0.00%)
As of 06/18/2026 04:10 PM Eastern

About SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Advanced

Key Stats

Today's Range
$60.17
$61.46
50-Day Range
$55.70
$61.04
52-Week Range
$40.26
$61.46
Volume
35,538 shs
Average Volume
77,980 shs
Market Capitalization
$375.40 million
Assets Under Management
$360.71 million
Dividend Yield
0.61%
Net Expense Ratio
0.35%
Aggregate Rating
Moderate Buy

ETF Overview

SPDR S&P Pharmaceuticals ETF Expenses

TypeXPHHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.35%0.56%0.57%0.51%0.53%
Other Expenses0.00%0.47%0.55%0.58%0.55%
Total Expense0.35%0.74%0.76%0.74%0.73%
Fee Waiver0.00%-0.71%-0.64%-0.70%-0.62%
Net Expense0.35%0.59%0.63%0.58%0.60%
Receive XPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SPDR S&P Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XPH ETF News Headlines

Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel
See More Headlines

XPH ETF - Frequently Asked Questions

SPDR S&P Pharmaceuticals ETF's stock was trading at $56.01 at the beginning of 2026. Since then, XPH stock has increased by 9.0% and is now trading at $61.04.

Top institutional investors of SPDR S&P Pharmaceuticals ETF include Bank of America Corp DE (13.20%), First Citizens Bank & Trust Co. (3.05%), Cetera Investment Advisers (0.93%) and Private Advisor Group LLC (0.91%).

Shares of XPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SPDR S&P Pharmaceuticals ETF investors own include NVIDIA (NVDA), Pfizer (PFE), Adobe (ADBE), Applied Materials (AMAT), Chevron (CVX), JPMorgan Chase & Co. (JPM) and Meta Platforms (META).

Fund Details

Issuer
SSgA
Fund Name
SPDR S&P Pharmaceuticals ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:XPH
Inception Date
6/19/2006
Fund Manager
Michael Feehily, Karl Schneider, Keith Richardson

Fund Focus

Asset Class
Equity
Benchmark
S&P Pharmaceuticals Select Industry Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
76

Fund Statistics

Assets Under Management
$360.71 million
Average Daily Volume
$56.36 thousand
Discount/Premium
-0.10%

Administrator, Advisor and Custodian

Administrator
State Street Global Advisors Funds Management, Inc.
Advisor
SSgA Funds Management, Inc.
Custodian
State Street Bank and Trust Company
Distributor
State Street Global Advisors Funds Distributors, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Citadel

Options

Optionable
Optionable
Options Volume
10
Put Options
0
Call Options
10
Short Interest
470,882 shs

Miscellaneous

Beta
0.61
Creation Unit
50,000
Creation Fee
$250.00
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Top 10 XPH Holdings

XPH Sector Exposure

XPH Industry Exposure


This page (NYSEARCA:XPH) was last updated on 6/21/2026 by MarketBeat.com Staff.
From Our Partners